Sana Biotechnology, a preclinical biotech developing engineered cell therapies for multiple indications, announced terms for its IPO on Thursday. The Seattle, WA-based company plans to raise $323 ...
eXoZymes Inc. is featured on the cover of the April issue of GEN Biotechnology with a paper introducing the term "exozymes" to clarify the concept of cell-free biomanufacturing, which produces ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback